Literature DB >> 29113282

Common mechanism of pathogenesis in various types of metastatic osteosarcoma.

Dongqi Wang1, Zongrang Song1, Zhan Wang2.   

Abstract

The present study aimed to investigate the common metastatic mechanism in various types of metastatic osteosarcoma (OS). Gene expression profiles generated from the metastatic OS KHOS and KRIB cell lines and the non-metastatic OS HOS cell line were compared. Two groups of differentially expressed genes (DEGs) between KHOS or KRIB and HOS were screened (P<0.01 and |fold change| ≥2) and then underwent Gene Ontology (GO) and pathway enrichment analyses. Subsequently, the protein-protein interaction (PPI) network was constructed and the subnetwork was mined. Furthermore, overlapping DEGs of these two groups were identified and pathway enrichment and regulatory network analyses were performed. A total of 1,552 and 1,330 DEGs from KHOS vs. HOS and KRIB vs. HOS were obtained, respectively. GO and pathway enrichment analyses of DEGs between KRIB and HOS, including anatomical structure morphogenesis and focal adhesion, were similar to those between KHOS and HOS. Vascular endothelial growth factor A and epidermal growth factor receptor were hub nodes in the PPI network for KHOS and KRIB. Subnetworks of these two groups were similar. In addition, 421 upregulated and 595 downregulated overlapping genes were enriched in the mitogen-activated protein kinase and transforming growth factor-β signaling pathways. Furthermore, seven vital transcription factors, including hes-related family bHLH transcription factor with YRPW motif 1 (HEY1), were obtained. Overall, different types of metastatic OS were shown to exhibit a similar mechanism of pathogenesis. With the exception of cell adhesion and angiogenesis, recapitulation of the morphogenetic processes facilitates OS tumor formation and metastasis. Genes such as HEY1 are important for metastatic OS. Further studies are required in order to confirm these results.

Entities:  

Keywords:  differentially expressed genes; metastatic osteosarcoma; module; protein-protein interaction network

Year:  2017        PMID: 29113282      PMCID: PMC5661405          DOI: 10.3892/ol.2017.6955

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  35 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

Review 3.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

4.  Role of morphogenetic factors in metastasis of mammary carcinoma cells.

Authors:  S Meiners; V Brinkmann; H Naundorf; W Birchmeier
Journal:  Oncogene       Date:  1998-01-08       Impact factor: 9.867

Review 5.  How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.

Authors:  Dennis P M Hughes
Journal:  Cancer Treat Res       Date:  2009

6.  Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.

Authors:  Xiaolin Wan; Arnulfo Mendoza; Chand Khanna; Lee J Helman
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

7.  In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Authors:  B Casar; I Rimann; H Kato; S J Shattil; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

8.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

Review 9.  The extracellular matrix: a dynamic niche in cancer progression.

Authors:  Pengfei Lu; Valerie M Weaver; Zena Werb
Journal:  J Cell Biol       Date:  2012-02-20       Impact factor: 10.539

Review 10.  The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.

Authors:  Michel Zimmermann; Abderrahim Zouhair; David Azria; Mahmut Ozsahin
Journal:  Radiat Oncol       Date:  2006-05-02       Impact factor: 3.481

View more
  4 in total

1.  Long noncoding RNA KCNQ1 opposite strand/antisense transcript 1 promotes osteosarcoma progression through miR-154-3p/KLF12.

Authors:  Qibo Zhang; Huachang Jiang; Youming Jin; Ning Zhang; Zhihua Mu; Yan Guo; Haitao Li
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 2.  Hedgehog signalling in the tumourigenesis and metastasis of osteosarcoma, and its potential value in the clinical therapy of osteosarcoma.

Authors:  Zhihong Yao; Lei Han; Yongbin Chen; Fei He; Bin Sun; Santosh Kamar; Ya Zhang; Yihao Yang; Cao Wang; Zuozhang Yang
Journal:  Cell Death Dis       Date:  2018-06-13       Impact factor: 8.469

3.  miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1.

Authors:  Xiangjun Liu; Chengfeng Zhang; Cunhua Wang; Jianwei Sun; Deliang Wang; Yansheng Zhao; Xiaohui Xu
Journal:  Oncol Lett       Date:  2018-06-11       Impact factor: 2.967

Review 4.  Targeting ferroptosis in osteosarcoma.

Authors:  Jiazheng Zhao; Yi Zhao; Xiaowei Ma; Benzheng Zhang; Helin Feng
Journal:  J Bone Oncol       Date:  2021-07-12       Impact factor: 4.072

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.